Country Reports — Market Intelligence by Geography

Markets NXT — A Montclaire & Stein Venture

A Century of Global Intelligence Behind Every Report

Markets NXT builds on a legacy dating to the early 1900s, when economists Edgar Montclaire and Johann Stein began advising enterprises across Europe and North America on industrial expansion and globalization. Over more than a century, Montclaire & Stein accumulated institutional knowledge spanning economic intelligence and market dynamics across geographies — forming the analytical foundation behind every report we publish today.

Why Country-Level Intelligence Matters

Global markets are not uniform. Regulatory environments, consumer behavior, industrial composition, and competitive dynamics differ significantly by country. Country-specific research helps businesses:

  • Accurately size and forecast a market within a defined geography
  • Understand local demand drivers, supply chains, and competition
  • Navigate country-specific regulatory and policy frameworks
  • Identify entry points, opportunities, and risk factors at a national level

What Our Country Reports Cover

Each report delivers institutional-grade intelligence across: market sizing and forecasting, industry segmentation, competitive landscape, regulatory environment, macroeconomic context, and strategic recommendations — all grounded in conservative, multi-source validated methodology.

Institutional Rigour at the Most Competitive Pricing

Markets NXT offers country-specific research at the most competitive pricing in the industry, without compromising analytical standards. Our reports serve growth-stage businesses, investment firms, and consulting teams that need board-level intelligence without enterprise-level costs.

Explore Reports by Country

Browse and filter below to find market research reports for the country of your interest. Coverage spans North America, Europe, Asia Pacific, Latin America, the Middle East, and Africa.

Showing 291 - 300 of 344 reports

U.S. Arteriovenous Malformation Market Size, Share & Forecast 2026–2034

Report Highlights Country: United States Market: Arteriovenous Malformation Market Market Size 2024: USD 1.42 Billion Market Size 2032: USD 2.61 Billion CAGR: 7.9% Base Year: 2025 Forecast Period: 2026–2032 Analyst Findings and Recommendations Finding 01 — Stereotactic Radiosurgery Dominates Revenue: Elekta AB's Leksell Gamma Knife … Read More
Published September 2026

U.S. Genetic Engineering Market Size, Share & Forecast 2026–2034

Report Highlights Country: United States Market: Genetic Engineering Market Size 2024: USD 11.4 Billion Market Size 2032: USD 28.7 Billion CAGR: 12.2% Base Year: 2025 Forecast Period: 2026–2032 Analyst Findings and Recommendations Finding 01 — CRISPR Therapeutics Dominates Pipeline: Vertex Pharmaceuticals and CRISPR Therapeutics' Casgevy … Read More
Published August 2026

U.S. Fungal Endocarditis Market Size, Share & Forecast 2026–2034

Report Highlights Country: United States Market: Fungal Endocarditis Market Size 2024: USD 312.6 Million Market Size 2032: USD 581.4 Million CAGR: 8.1% Base Year: 2025 Forecast Period: 2026–2032 Analyst Findings and Recommendations Finding 01 — Echinocandin Resistance Accelerating: Candida auris, now endemic in over 30 … Read More
Published August 2026

U.S. Flow Cytometer Reagents Market Size, Share & Forecast 2026–2034

Report Highlights Market Size 2024: USD 1.82 billion Market Size 2032: USD 3.47 billion CAGR: 8.4% Market Definition: The U.S. flow cytometer reagents market encompasses antibodies, dyes, buffers, calibration beads, and assay kits used in fluorescence-based cell analysis for clinical diagnostics, drug discovery, and research … Read More
Published August 2026

U.S. Nano Biotechnology Market Size, Share & Forecast 2026–2034

Report Highlights Country: United States Market: Nano Biotechnology Market Size 2024: USD 18.6 Billion Market Size 2032: USD 52.4 Billion CAGR: 13.8% Base Year: 2025 Forecast Period: 2026–2032 Analyst Findings and Recommendations Finding 01 — Lipid Nanoparticle Supply Concentration: Over 74% of U.S. GMP-grade lipid … Read More
Published August 2026

U.S. Microalbumin Test Market Size, Share & Forecast 2026–2034

Report Highlights Market Size 2024: USD 412.6 Million Market Size 2032: USD 718.3 Million CAGR: 7.2% Market Definition: The U.S. microalbumin test market encompasses diagnostic assays, reagents, analyzers, and point-of-care devices used to detect and quantify albumin in urine at sub-clinical levels, primarily for early … Read More
Published August 2026

U.S. Life Sciences BPO Market Size, Share & Forecast 2026–2034

Report Highlights Market Size 2024: $9.2 billion Market Size 2032: $18.7 billion CAGR: 9.3% Market Definition: The U.S. Life Sciences BPO market encompasses third-party outsourcing of business processes including clinical data management, pharmacovigilance, regulatory affairs, finance, and commercial operations for pharmaceutical, biotechnology, and medical device … Read More
Published August 2026

U.S. Lactate Dehydrogenase Test Market Size, Share & Forecast 2026–2034

Report Highlights Market Size 2024: USD 1.42 Billion Market Size 2032: USD 2.31 Billion CAGR: 6.3% Market Definition: The U.S. lactate dehydrogenase (LDH) test market encompasses diagnostic assays measuring LDH enzyme activity in blood, urine, and cerebrospinal fluid. Applications span oncology monitoring, cardiac injury assessment, … Read More
Published August 2026

U.S. Hematology Diagnostics Market Size, Share & Forecast 2026–2034

Report Highlights Market Size 2024: USD 3.8 Billion Market Size 2032: USD 6.7 Billion CAGR: 7.4% Market Definition: The U.S. hematology diagnostics market encompasses instruments, reagents, and software used to analyze blood cells, coagulation, and hemostatic function for clinical decision-making. It includes automated hematology analyzers, … Read More
Published August 2026

U.S. Gitelman Syndrome Market Size, Share & Forecast 2026–2034

Report Highlights Country: United States Market: Gitelman Syndrome Market Size 2024: USD 312 million Market Size 2032: USD 589 million CAGR: 8.3% Base Year: 2025 Forecast Period: 2026–2032 Analyst Findings and Recommendations Finding 01 — Orphan Designation Drives Valuation: Cadrenal Therapeutics' tecarfarin holds FDA Orphan … Read More
Published August 2026